• Something wrong with this record ?

Demographic and Clinical Characteristics of Patients With Charcot Neuro-Osteoarthropathy in People With Diabetes Mellitus in Six Countries: A Multicenter Observational Study From 1996 to 2022

EB. Jude, C. Siafarikas, A. Rastogi, R. Bem, T. Tankova, MF. Kong, J. LaFontaine, J. Pappachan, N. Tentolouris

. 2025 ; 2025 (-) : 4275741. [pub] 20250108

Language English Country United States

Document type Journal Article, Observational Study, Multicenter Study

Persistent link   https://www.medvik.cz/link/bmc25010304

Aim: To describe the demographic and clinical characteristics of patients with Charcot neuro-osteoarthropathy (CNO) and to examine for differences between participants with Type 1 diabetes mellitus (DM) (T1DM) and Type 2 diabetes mellitus (T2DM). Materials and Methods: Multicenter observational study in eight diabetic foot clinics in six countries between January 1, 1996, and December 31, 2022. Demographic, clinical, and laboratory parameters were obtained from the medical records. Analyses were performed using parametric or nonparametric statistical tests for variables with normally or nonnormally distributed values, respectively. Comparisons of the qualitative data were performed using the chi-square test. Results: Seven hundred seventy-four patients with DM and CNO were included. The mean age at diagnosis of CNO was 54.5 ± 11.7 years, and the median (interquartile range (IQR)) diabetes duration at diagnosis of CNO was 15 (10-22) years. Among participants, 71.8% (n = 546) were male and 83.2% (n = 634) had T2DM. Neuropathy was present in 91.7% (n = 688), retinopathy in 60.2% (n = 452), and nephropathy in 45.2% (n = 337). Subjects with T1DM, compared to T2DM, were diagnosed with CNO at a younger age (46.9 ± 11.0 vs. 57.9 ± 10.2 years, p < 0.001), had longer diabetes duration (median value (IQR): 29.0 (21.0-38.0) vs. 14.0 (8.0-20.0) years, p < 0.001), and had more often microvascular complications (neuropathy, 95.2% in T1DM vs. 87.4% in T2DM, p = 0.006; retinopathy, 83.3% vs. 55.4%, p < 0.001; and nephropathy 67.5% vs. 40.5%, p < 0.001). Conclusions: CNO is predominant in males, occurs in long-standing DM, and is often accompanied by microvascular complications. People with T1DM, compared to those with T2DM, are affected at a younger age, have longer diabetes duration, and have more often microvascular complications.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25010304
003      
CZ-PrNML
005      
20250429135259.0
007      
ta
008      
250415e20250108xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1155/jdr/4275741 $2 doi
035    __
$a (PubMed)39817102
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Jude, E B $u Department of Diabetes and Endocrinology, Tameside and Glossop Integrated Care NHS Foundation Trust, Ashton Under Lyne and University of Manchester and Manchester Metropolitan University, Manchester, UK $1 https://orcid.org/0000000231864122
245    10
$a Demographic and Clinical Characteristics of Patients With Charcot Neuro-Osteoarthropathy in People With Diabetes Mellitus in Six Countries: A Multicenter Observational Study From 1996 to 2022 / $c EB. Jude, C. Siafarikas, A. Rastogi, R. Bem, T. Tankova, MF. Kong, J. LaFontaine, J. Pappachan, N. Tentolouris
520    9_
$a Aim: To describe the demographic and clinical characteristics of patients with Charcot neuro-osteoarthropathy (CNO) and to examine for differences between participants with Type 1 diabetes mellitus (DM) (T1DM) and Type 2 diabetes mellitus (T2DM). Materials and Methods: Multicenter observational study in eight diabetic foot clinics in six countries between January 1, 1996, and December 31, 2022. Demographic, clinical, and laboratory parameters were obtained from the medical records. Analyses were performed using parametric or nonparametric statistical tests for variables with normally or nonnormally distributed values, respectively. Comparisons of the qualitative data were performed using the chi-square test. Results: Seven hundred seventy-four patients with DM and CNO were included. The mean age at diagnosis of CNO was 54.5 ± 11.7 years, and the median (interquartile range (IQR)) diabetes duration at diagnosis of CNO was 15 (10-22) years. Among participants, 71.8% (n = 546) were male and 83.2% (n = 634) had T2DM. Neuropathy was present in 91.7% (n = 688), retinopathy in 60.2% (n = 452), and nephropathy in 45.2% (n = 337). Subjects with T1DM, compared to T2DM, were diagnosed with CNO at a younger age (46.9 ± 11.0 vs. 57.9 ± 10.2 years, p < 0.001), had longer diabetes duration (median value (IQR): 29.0 (21.0-38.0) vs. 14.0 (8.0-20.0) years, p < 0.001), and had more often microvascular complications (neuropathy, 95.2% in T1DM vs. 87.4% in T2DM, p = 0.006; retinopathy, 83.3% vs. 55.4%, p < 0.001; and nephropathy 67.5% vs. 40.5%, p < 0.001). Conclusions: CNO is predominant in males, occurs in long-standing DM, and is often accompanied by microvascular complications. People with T1DM, compared to those with T2DM, are affected at a younger age, have longer diabetes duration, and have more often microvascular complications.
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé středního věku $7 D008875
650    12
$a diabetes mellitus 2. typu $x epidemiologie $x komplikace $7 D003924
650    12
$a diabetes mellitus 1. typu $x epidemiologie $x komplikace $7 D003922
650    12
$a neuropatická artropatie $x epidemiologie $7 D001177
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a diabetická noha $x epidemiologie $x diagnóza $7 D017719
650    _2
$a diabetické neuropatie $x epidemiologie $x diagnóza $7 D003929
650    _2
$a diabetická retinopatie $x epidemiologie $7 D003930
655    _2
$a časopisecké články $7 D016428
655    _2
$a pozorovací studie $7 D064888
655    _2
$a multicentrická studie $7 D016448
700    1_
$a Siafarikas, C $u First Department of Propaedeutic Internal Medicine, Medical School, National and Kapodistrian University of Athens, Laiko General Hospital, Athens, Greece $1 https://orcid.org/0009000090201962
700    1_
$a Rastogi, A $u Diabetes and Endocrinology, Post Graduate Institute of Medical Education and Research, Chandigarh, India
700    1_
$a Bem, R $u Diabetes Centre, Institute for Clinical and Experimental Medicine, Prague, Czech Republic $1 https://orcid.org/0000000341271846 $7 xx0104859
700    1_
$a Tankova, T $u Department of Endocrinology, Medical University of Sofia, Sofia, Bulgaria $1 https://orcid.org/0000000275721131
700    1_
$a Kong, M-F $u Diabetes and Endocrinology, University Hospitals of Leicester NHS Trust, Leicester, UK
700    1_
$a LaFontaine, J $u UTRGV School of Podiatric Medicine, Department of Podiatric Medicine, Surgery and Biomechanics, Harlingen, Texas, USA
700    1_
$a Pappachan, J $u Diabetes and Endocrinology, Lancashire Teaching Hospitals NHS Foundation Trust, Chorley, UK
700    1_
$a Tentolouris, N $u First Department of Propaedeutic Internal Medicine, Medical School, National and Kapodistrian University of Athens, Laiko General Hospital, Athens, Greece $1 https://orcid.org/0000000306152534
773    0_
$w MED00181720 $t Journal of diabetes research $x 2314-6753 $g Roč. 2025 (20250108), s. 4275741
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39817102 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250415 $b ABA008
991    __
$a 20250429135254 $b ABA008
999    __
$a ok $b bmc $g 2311580 $s 1247385
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 2025 $c - $d 4275741 $e 20250108 $i 2314-6753 $m Journal of diabetes research $n J Diabetes Res $x MED00181720
LZP    __
$a Pubmed-20250415

Find record

Citation metrics

Archiving options